ArticleJAMA network open2021

Assessment of Outcomes Associated With the Use of Newly Approved Oncology Drugs in Medicare Beneficiaries.

Angela K Green et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.